MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research (A*STAR)
BioChromato Inc. reports on installation of over 1200 units of its Smart Evaporator C1 - a compact system that delivers rapid concentration or complete drying of samples in even high boiling solvents such as DMSO, DMF or water
Beckman Coulter today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its PK7400 Automated Microplate System and the system's reagents have completed FDA approval. Designed for use in blood donor and plasma centers, as well as large reference laboratories, the PK7400 Automated Microplate System offers the industry's highest throughput for a single analyzer in its class and is now available in countries across Europe, Canada and the United States.
Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has begun work with the UK government’s CONDOR programme to evaluate and clinically validate the high throughput COVID-19 bead-assisted mass spectrometry (“BAMS”) laboratory assay developed with Adeptrix
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it received approval for a pre-market approval (PMA) supplement from the U.S. Food and Drug Administration (FDA) for an expanded version of its BD Onclarity™ HPV Assay
Autoscribe Informatics, a leading global laboratory informatics provider, announced the latest release of the Matrix Instrument Data Acquisition System (MIDAS). This release continues the company’s commitment to helping their customers maximize the value of their laboratory informatics investment
Cormeum Lab Services LLC, a high-volume Clinical Laboratory Improvement Amendments (CLIA) certified medical lab based in Marrero, Louisiana, recently received approval of its Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a PCR-based SARS-CoV-2 test
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2 IgG using its GSP/DELFIA platform, enabling processing of up to 5,000 samples per day